Shattuck Labs, Inc. (STTK)

↓ Download CSV

CIK 0001680367 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Shattuck Labs, Inc. reported revenue of $1.00M, down 82.5% from the prior year. The company ran a net loss, with a net margin of -4880.9%. It held $91.03M in total assets against $8.64M in total liabilities.

Key ratios (FY2025)

-5150.8%
Operating margin
-4880.9%
Net margin
-59.2%
Return on equity
-82.5%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$1.00M$5.72M$1.66M$652.0K$30.02M$9.93M$9.89M
Operating Income-$51.51M-$80.57M-$91.96M-$103.33M-$45.27M-$36.93M-$25.07M
Net Income-$48.81M-$75.41M-$87.30M-$101.94M-$44.97M-$36.60M-$23.98M
EPS (Diluted)$-0.70$-1.49$-2.05$-2.41$-1.07$-2.36
Total Assets$91.03M$91.05M$159.56M$205.32M$298.58M$348.99M$44.97M
Total Liabilities$8.64M$11.42M$14.86M$29.17M$26.80M$39.13M$30.45M
Shareholders' Equity$82.39M$79.63M$144.71M$176.16M$271.79M$309.86M-$34.55M-$11.08M
Cash & Equivalents$54.19M$57.39M$125.63M$47.38M$92.27M$157.90M$7.01M
Operating Cash Flow-$39.88M-$60.52M-$81.23M-$94.50M-$57.12M-$33.66M-$20.98M
Capital Expenditures$71.0K$59.0K$407.0K$11.61M$7.93M$727.0K$470.0K
Shares Outstanding63.28M47.71M47.26M42.39M42.34M41.77M7.60M